Chromosomal instability, aneuploidy and routine high-resolution DNA content analysis in oral cancer risk evaluation

Future Oncology

Volumn 8, Issue 10, 2012, Pages 1257-1271

  Giaretti, Walter ^a   Pentenero, Monica ^b   Gandolfo, Sergio ^b   Castagnola, Patrizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

aneuploidy; chromosomal instability; DNA flow cytometry; DNA image cytometry; oral 'field cancerization theory; oral cancer; oral potentially malignant disorders

Indexed keywords

B RAF KINASE; CHEMOKINE RECEPTOR CXCR4; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; EPIDERMAL GROWTH FACTOR RECEPTOR; FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN MAD1; PROTEIN MAD2; PROTEIN P16; PROTEIN P53; RAS PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANEUPLOIDY; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DNA CONTENT; DNA REPAIR; ENZYME INACTIVATION; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MORBIDITY; MOUTH CANCER; PRIORITY JOURNAL; REVIEW; S PHASE CELL CYCLE CHECKPOINT; SURVIVAL RATE; SURVIVAL TIME; UPREGULATION;

ANEUPLOIDY; CHROMOSOMAL INSTABILITY; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 84868598818     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.116     Document Type: Review

References (144)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61(2), 69-90 (2011
2. Parkin DM. The global burden of urinary bladder cancer. Scand. J. Urol. Nephrol. Suppl. (218), 12-20 (2008
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127(12), 2893-2917 (2010
4. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: An overview of the literature. J. Oral Pathol. Med. 37(1), 1-10 (2008 (Pubitemid 350264786)
5. Petti S. Pooled estimate of world leukoplakia prevalence: A systematic review. Oral Oncol. 39(8), 770-780 (2003 (Pubitemid 38373461)
6. Reibel J. Prognosis of oral pre-malignant lesions: Significance of clinical, histopathological, and molecular biological characteristics. Crit. Rev. Oral Biol. Med. 14(1), 47-62 (2003
7. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: Predictive value, utility, weaknesses and scope for improvement. J. Oral Pathol. Med. 37(3), 127-133 (2008 (Pubitemid 351178405)
8. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter's concept of field cancerization: Evidence and clinical implications. Cancer Res. 63(8), 1727-1730 (2003 (Pubitemid 36460827)
9. Braakhuis BJ, Tabor MP, Leemans CR, van Der Waal I, Snow GB, Brakenhoff RH. Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions. Head Neck 24(2), 198-206 (2002 (Pubitemid 34111517)
10. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6(5), 963-968 (1953
11. Tabor MP, Brakenhoff RH, van Houten VM et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin. Cancer Res. 7(6), 1523-1532 (2001 (Pubitemid 32708615)
12. Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S. Molecular markers in oral epithelial dysplasia: review. J. Oral Pathol. Med. 38(10), 737-752 (2009
13. Bhattacharya A, Roy R, Snijders AM et al. Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. Clin. Cancer Res. 17(22), 7024-7034 (2011
14. da Silva SD, Ferlito A, Takes RP et al. Advances and applications of oral cancer basic research. Oral Oncol. 47(9), 783-791 (2011
15. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11(1), 9-22 (2011
16. Bruckman KC, Schonleben F, Qiu W, Woo VL, Su GH. Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 110(5), 632-637 (2010
17. Kozaki K, Imoto I, Pimkhaokham A et al. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma. Cancer Sci. 97(12), 1351-1358 (2006 (Pubitemid 44614987)
18. Chang SE, Bhatia P, Johnson NW et al. Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int. J. Cancer 48(3), 409-412 (1991
19. Kiaris H, Spandidos DA, Jones AS, Vaughan ED, Field JK. Mutations, expression and genomic instability of the H-ras protooncogene in squamous cell carcinomas of the head and neck. Br. J. Cancer 72(1), 123-128 (1995
20. Mishima K, Yamada E, Masui K et al. Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma. Mod. Pathol 11(9), 886-891 (1998 (Pubitemid 28440886)
21. Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 54(12), 3153-3159 (1994 (Pubitemid 24208920)
22. Sheu JJ, Hua CH, Wan L et al. Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma. Cancer Res. 69(6), 2568-2576 (2009
23. Kaminagakura E, Werneck da Cunha I, Soares FA, Nishimoto IN, Kowalski LP. CCND1 amplification and protein overexpression in oral squamous cell carcinoma of young patients. Head Neck 33(10), 1413-1419 (2011
24. Mishra A, Bharti AC, Varghese P, Saluja D, Das BC. Differential expression and activation of NF-kB family proteins during oral carcinogenesis: role of high risk human papillomavirus infection. Int. J. Cancer 119(12), 2840-2850 (2006 (Pubitemid 44846236)
25. Rehman AO, Wang CY. CXCL12/SDF-1a activates NF-kB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex. Int. J. Oral Sci. 1(3), 105-118 (2009
26. Liang L, Zhao M, Xu Z, Yokoyama KK, Li T. Molecular cloning and characterization of CIDE-3, a novel member of the cell-deathinducing DNA-fragmentation-factor (DFF45)-like effector family. Biochem. J. 370(Pt 1), 195-203 (2003
27. Kayahara H, Yamagata H, Tanioka H, Miki T, Hamakawa H. Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma. J. Hum. Genet. 46(6), 335-341 (2001 (Pubitemid 32524631)
28. Hannon GJ, Beach D. p15INK4B is a potential effector of TGF-b-induced cell cycle arrest. Nature 371(6494), 257-261 (1994
29. Kresty LA, Mallery SR, Knobloch TJ et al. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia. Cancer Res. 62(18), 5295-5300 (2002 (Pubitemid 35024605)
30. Hall GL, Shaw RJ, Field EA et al. p16 promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia. Cancer Epidemiol. Biomarkers Prev. 17(8), 2174-2179 (2008
31. Ostwald C, Gogacz P, Hillmann T et al. p53 mutational spectra are different between squamous-cell carcinomas of the lip and the oral cavity. Int. J. Cancer 88(1), 82-86 (2000
32. Kato K, Kawashiri S, Yoshizawa K et al. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: Correlation with clinicopathological features and prognosis. J. Oral Pathol. Med. doi:10.1111/j.1600-0714.2011.01032.x (2011) (Epub ahead of print
33. Kondo Y, Nagai K, Nakahata S et al. Overexpression of the DNA sensor proteins, AIM2 and IFI16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation. Cancer Sci. 103(4), 782-790 (2012
34. Tanimoto K, Hayashi S, Tsuchiya E et al. Abnormalities of the FHIT gene in human oral carcinogenesis. Br. J. Cancer 82(4), 838-843 (2000 (Pubitemid 30085236)
35. Martin CL, Reshmi SC, Ried T et al. Chromosomal imbalances in oral squamous cell carcinoma: Examination of 31 cell lines and review of the literature. Oral Oncol. 44(4), 369-382 (2008 (Pubitemid 351380982)
36. Jordan RC, Macabeo-Ong M, Shiboski CH et al. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Clin. Cancer Res. 10(19), 6460-6465 (2004 (Pubitemid 39346541)
37. Cervigne NK, Reis PP, Machado J et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum. Mol. Genet. 18(24), 4818-4829 (2009
38. Holland AJ, Cleveland DW. Losing balance: The origin and impact of aneuploidy in cancer. EMBO Reports 13(6), 501-514 (2012
39. McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: Therapeutic and diagnostic challenges. EMBO Reports 13(6), 528-538 (2012
40. Pfau SJ, Amon A. Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Reports 13(6), 515-527 (2012
41. Rabinovitch PS, Dziadon S, Brentnall TA et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res. 59(20), 5148-5153 (1999 (Pubitemid 29503975)
42. Risques RA, Lai LA, Brentnall TA et al. Ulcerative colitis is a disease of accelerated colon aging: Evidence from telomere attrition and DNA damage. Gastroenterol. 135(2), 410-418 (2008
43. Giaretti W. A model of DNA aneuploidization and evolution in colorectal cancer. Lab. Invest. 71(6), 904-910 (1994
44. Torres EM, Williams BR, Amon A. Aneuploidy: Cells losing their balance. Genetics 179(2), 737-746 (2008
45. Reshmi SC, Gollin SM. Chromosomal instability in oral cancer cells. J. Dent. Res. 84(2), 107-117 (2005 (Pubitemid 43822042)
46. Boland CR, Komarova NL, Goel A. Chromosomal instability and cancer: not just one CINgle mechanism. Gut 58(2), 163-164 (2009
47. Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR. Defining 'chromosomal instability'. Trends Genet. 24(2), 64-69 (2008
48. Panigrahi AK, Pati D. Road to the crossroads of life and death: Linking sister chromatid cohesion and separation to aneuploidy, apoptosis and cancer. Crit. Rev. Oncol. Hematol. 72(3), 181-193 (2009
49. Holland AJ, Cleveland DW. Boveri revisited: Chromosomal instability, aneuploidy and tumorigenesis. Nat. Rev. Mol. Cell Biol. 10(7), 478-487 (2009
50. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability - an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11(3), 220-228 (2010
51. Suijkerbuijk SJ, Kops GJ. Preventing aneuploidy: The contribution of mitotic checkpoint proteins. Biochim. Biophys. Acta 1786(1), 24-31 (2008
52. Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr. Biol. 20(6), R285-R295 (2010
53. Plotz G, Zeuzem S, Raedle J. DNA mismatch repair and Lynch syndrome. J. Mol. Histol. 37(5-7), 271-283 (2006 (Pubitemid 44795630)
54. Barber TD, Mcmanus K, Yuen KW et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc. Natl Acad. Sci. USA 105(9), 3443-3448 (2008 (Pubitemid 351723572)
55. Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 180(4), 665-672 (2008 (Pubitemid 351397764)
56. Bakhoum SF, Thompson SL, Manning AL, Compton DA. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat. Cell Biol. 11(1), 27-35 (2009
57. Artandi SE, Depinho RA. Telomeres and telomerase in cancer. Carcinogenesis 31(1), 9-18 (2010
58. Kallioniemi A, Kallioniemi OP, Sudar D et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258(5083), 818-821 (1992
59. Albertson DG, Pinkel D. Genomic microarrays in human genetic disease and cancer. Hum. Mol. Genet. 12 Spec. No 2, R145-R152 (2003 (Pubitemid 37259326)
60. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 144(5), 646-674 (2011
61. Korkola J, Gray JW. Breast cancer genomes - form and function. Curr. Opin Genet. Dev. 20(1), 4-14 (2010
62. Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19(6), 701-714 (2011
63. Fava LL, Kaulich M, Nigg EA, Santamaria A. Probing the in vivo function of Mad1:C-Mad2 in the spindle assembly checkpoint. EMBO J. 30(16), 3322-3336 (2011
64. Ricke RM, van Deursen JM. Aurora B hyperactivation by Bub1 overexpression promotes chromosome missegregation. Cell Cycle 10(21), 3645-3651 (2011
65. Ricke RM, Jeganathan KB, van Deursen JM. Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. J. Cell Biol. 193(6), 1049-1064 (2011
66. Elowe S. Bub1 and BubR1: At the interface between chromosome attachment and the spindle checkpoint. Mol. Cell. Biol. 31(15), 3085-3093 (2011
67. Yamamoto Y, Matsuyama H, Chochi Y et al. Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet. Cytogenet. 174(1), 42-47 (2007 (Pubitemid 46365984)
68. Solomon DA, Kim T, Diaz-Martinez LA et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333(6045), 1039-1043 (2011
69. Kim MS, Kim SS, Je EM, Yoo NJ, Lee SH. Mutational and expressional analyses of STAG2 gene in solid cancers. Neoplasma 59(5), 524-529 (2012
70. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat. Genet. 38(9), 1043-1048 (2006 (Pubitemid 44325930)
71. Hemmer J, Kreidler J. Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity. Comparison with clinical staging and histologic grading. Cancer 66(2), 317-320 (1990 (Pubitemid 20205914)
72. Hemmer J, Thein T, Van Heerden WF. The value of DNA flow cytometry in predicting the development of lymph node metastasis and survival in patients with locally recurrent oral squamous cell carcinoma. Cancer 79(12), 2309-2313 (1997 (Pubitemid 27251012)
73. Torres EM, Sokolsky T, Tucker CM et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317(5840), 916-924 (2007 (Pubitemid 47301313)
74. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11(1), 25-36 (2007 (Pubitemid 46070223)
75. Williams BR, Prabhu VR, Hunter KE et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322(5902), 703-709 (2008
76. Sheltzer JM, Blank HM, Pfau SJ et al. Aneuploidy drives genomic instability in yeast. Science 333(6045), 1026-1030 (2011
77. Kolodner RD, Cleveland DW, Putnam CD. Aneuploidy drives a mutator phenotype in cancer. Science 333(6045), 942-943 (2011
78. Bremmer JF, Braakhuis BJ, Brink A et al. Comparative evaluation of genetic assays to identify oral pre-cancerous fields. J. Oral Pathol. Med. 37(10), 599-606 (2008
79. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N. Engl. J. Med. 345(26), 1890-1900 (2001 (Pubitemid 33716564)
80. Leemans CR, Tiwari R, Nauta JJ, van Der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73(1), 187-190 (1994 (Pubitemid 24012742)
81. Sankaranarayanan R, Ramadas K, Thomas G et al. Effect of screening on oral cancer mortality in Kerala, India: A clusterrandomised controlled trial. Lancet 365(9475), 1927-1933 (2005 (Pubitemid 40797502)
82. Schepman KP, van Der Meij EH, Smeele LE, Van Der Waal I. Malignant transformation of oral leukoplakia: A follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol. 34(4), 270-275 (1998 (Pubitemid 28318253)
83. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Kummer JA, Leemans CR, Braakhuis BJ. Genetically altered fields as origin of locally recurrent head and neck cancer: A retrospective study. Clin. Cancer Res. 10(11), 3607-3613 (2004 (Pubitemid 38697593)
84. Bremmer JF, Graveland AP, Brink A et al. Screening for oral precancer with noninvasive genetic cytology. Cancer Prev. Res. (Phila.) 2(2), 128-133 (2009
85. Rosin MP, Cheng X, Poh C et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin. Cancer Res. 6(2), 357-362 (2000 (Pubitemid 30111451)
86. Giaretti W, Maffei M, Pentenero M et al. Genomic aberrations in normal appearing mucosa fields distal from oral potentially malignant lesions. Cell. Oncol. 35(1), 43-52 (2012
87. Pentenero M, Donadini A, Di Nallo E et al. Field effect in oral precancer as assessed by DNA flow cytometry and array-CGH. J. Oral Pathol. Med. 41(2), 119-123 (2012
88. Noutomi Y, Oga A, Uchida K et al. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways. J. Pathol. 210(1), 67-74 (2006 (Pubitemid 44288182)
89. Lavelle CL, Scully C. Criteria to rationalize population screening to control oral cancer. Oral Oncol. 41(1), 11-16 (2005 (Pubitemid 39647114)
90. Newton JA, Camplejohn RS, Mcgibbon DH. The flow cytometry of melanocytic skin lesions. Br. J. Cancer 58(5), 606-609 (1988 (Pubitemid 19010710)
91. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify lowand high-risk patient subsets. Am. J. Gastroenterol. 95(7), 1669-1676 (2000 (Pubitemid 30485000)
92. Nankivell P, Mehanna H. Oral dysplasia: biomarkers, treatment, and follow-up. Curr. Oncol. Rep. 13(2), 145-152 (2011
93. Couzin J. Cancer research. Fake data, but could the idea still be right? Science 313(5784), 154 (2006
94. Haroske G, Baak JP, Danielsen H et al. Fourth updated ESACP consensus report on diagnostic DNA image cytometry. Anal. Cell. Pathol. 23(2), 89-95 (2001 (Pubitemid 34451106)
95. Ormerod MG, Tribukait B, Giaretti W. Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. DNA flow cytometry task force of the European Society for analytical cellular pathology. Anal. Cell. Pathol. 17(2), 103-110 (1998 (Pubitemid 29067549)
96. Shapiro HM. Practical Flow Cytometry (4th Edition). Wiley, Hoboken, NJ, USA (2003
97. Brouns ER, Bloemena E, Belien JA, Broeckaert MA, Aartman IH, van der Waal I. DNA ploidy measurement in oral leukoplakia: Different results between flow and image cytometry. Oral Oncol. 48(7), 636-640 (2012
98. Donadini A, Maffei M, Cavallero A et al. Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry. Cell. Oncol. 32(5-6), 373-383 (2010
99. Darzynkiewicz Z, Juan G. DNA content measurement for DNA ploidy and cell cycle analysis. Curr. Protoc. Cytom. 7.5.1-7.5.24 (2001
100. Heinlein C, Deppert W, Braithwaite AW, Speidel D. A rapid and optimization-free procedure allows the in vivo detection of subtle cell cycle and ploidy alterations in tissues by flow cytometry. Cell Cycle 9(17), 3584-3590 (2010
101. Shankey TV, Rabinovitch PS, Bagwell B et al. Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology. Cytometry 14(5), 472-477 (1993 (Pubitemid 23191954)
102. Corver WE, Ter Haar NT, Dreef EJ et al. High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffinembedded tissues. J. Pathol. 206(2), 233-241 (2005 (Pubitemid 40754028)
103. Fleskens SJ, Takes RP, Otte-Holler I et al. Simultaneous assessment of DNA ploidy and biomarker expression in paraffin-embedded tissue sections. Histopathology 57(1), 14-26 (2010
104. Otto FJ. High-resolution analysis of nuclear DNA employing the fluorochrome DAPI. Methods Cell Biol. 41, 211-217 (1994
105. van Zyl AW, van Heerden MB, Langenegger E, van Heerden WF. Correlation between dysplasia and ploidy status in oral leukoplakia. Head Neck Pathol. 6(3), 322-327 (2012
106. Faranda A, Costa A, Canova S, Abolafio G, Silvestrini R. Image and flow cytometric analyses of DNA content in human solid tumors. A comparative study. Anal. Quant. Cytol. Histol. 19(4), 338-344 (1997 (Pubitemid 27352133)
107. Gandour-Edwards RF, Donald PJ, Yu TL, Howard RR, Teplitz RL. DNA content of head and neck squamous carcinoma by flow and image cytometry. Arch. Otolaryngol. Head Neck Surg. 120(3), 294-297 (1994 (Pubitemid 24097731)
108. Berlinger NT, Malone BN, Kay NE. A comparison of flow cytometric DNA analyses of fresh and fixed squamous cell carcinomas. Arch. Otolaryngol. Head Neck Surg. 113(12), 1301-1306 (1987 (Pubitemid 18034613)
109. Chen TL, Luo I, Mikhail N, Raskova J, Raska K Jr. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. Cytometry 22(3), 181-189 (1995
110. Navone R, Pentenero M, Rostan I et al. Oral potentially malignant lesions: first-level micro-histological diagnosis from tissue fragments sampled in liquid-based diagnostic cytology. J. Oral Pathol. Med. 37(6), 358-363 (2008 (Pubitemid 351814326)
111. Kuffer R, Lombardi T. Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia (OIN Oral Oncol. 38(2), 125-130 (2002 (Pubitemid 34164562)
112. International Agency for Research on Cancer. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Barnes L, Eveson JW, Reichart P, Sidranksy D (Eds). IARC Press, Lyon, France (2005
113. Pentenero M, Carrozzo M, Pagano M et al. Oral mucosal dysplastic lesions and early squamous cell carcinomas: Underdiagnosis from incisional biopsy. Oral Dis. 9(2), 68-72 (2003 (Pubitemid 36460017)
114. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Oral premalignant lesions: Is a biopsy reliable? J. Oral Pathol. Med. 36(5), 262-266 (2007 (Pubitemid 46632607)
115. Bundgaard T, Sorensen FB, Gaihede M, Sogaard H, Overgaard J. Stereologic, histopathologic, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas. Cancer 70(1), 1-13 (1992
116. Lippman SM, Hong WK. Molecular markers of the risk of oral cancer. N. Engl. J. Med. 344(17), 1323-1326 (2001 (Pubitemid 32372968)
117. Saito T, Notani K, Miura H et al. DNA analysis of oral leukoplakia by flow cytometry. Int. J. Oral Maxillofac. Surg. 20(5), 259-263 (1991
118. Saito T, Yamashita T, Notani K et al. Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings. Int. J. Oral Maxillofac. Surg. 24(1 Pt 1), 44-47 (1995
119. Scully C, Burkhardt A. Tissue markers of potentially malignant human oral epithelial lesions. J. Oral Pathol. Med. 22(6), 246-256 (1993 (Pubitemid 23235159)
120. Angadi PV, Savitha JK, Rao SS, Sivaranjini Y. Oral field cancerization: Current evidence and future perspectives. Oral Maxillofac. Surg. 16(2), 171-180 (2012
121. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL. Clinical implications and utility of field cancerization. Cancer Cell Int. 7, 2 (2007
122. Grassel-Pietrusky R, Deinlein E, Hornstein OP. DNA-ploidy rates in oral leukoplakias determined by flow-cytometry. J. Oral Pathol. 11(6), 434-438 (1982 (Pubitemid 13169356)
123. Pentenero M, Giaretti W, Navone R et al. DNA aneuploidy and dysplasia in oral potentially malignant disorders: Association with cigarette smoking and site. Oral Oncol. 45(10), 887-890 (2009
124. Saito T, Mizuno S, Notani K et al. Flow cytometric analysis of cell cycle fractions in oral leukoplakia. Int. J. Oral Maxillofac. Surg. 27(3), 217-221 (1998 (Pubitemid 128363266)
125. Abou-Elhamd KE, Habib TN. The flow cytometric analysis of premalignant and malignant lesions in head and neck squamous cell carcinoma. Oral Oncol. 43(4), 366-372 (2007 (Pubitemid 46413984)
126. Bremmer JF, Brakenhoff RH, Broeckaert MA et al. Prognostic value of DNA ploidy status in patients with oral leukoplakia. Oral Oncol. 47(10), 956-960 (2011
127. Femiano F, Scully C. DNA cytometry of oral leukoplakia and oral lichen planus. Med. Oral Patol. Oral Cir. Bucal 10(Suppl. 1), e9-e14 (2005
128. Khanna R, Agarwal A, Khanna S, Basu S, Khanna AK. S-phase fraction and DNA ploidy in oral leukoplakia. ANZ J. Surg. 80(7-8), 548-551 (2010
129. Bradley G, Odell EW, Raphael S et al. Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. Br. J. Cancer 103(9), 1432-1442 (2010
130. Warnakulasuriya S, Kovacevic T, Madden P et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J. Oral Pathol. Med. (2011
131. Torres-Rendon A, Stewart R, Craig GT, Wells M, Speight PM. DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression. Oral Oncol. 45(6), 468-473 (2009
132. Hogmo A, Kuylenstierna R, Lindholm J, Nathansson A, Auer G, Munck-Wikland E. Nuclear DNA content and p53 overexpression in stage I squamous cell carcinoma of the tongue compared with advanced tongue carcinomas. Mol. Pathol. 51(5), 268-272 (1998 (Pubitemid 28480344)
133. Castagnola P, Malacarne D, Scaruffi P et al. Chromosomal aberrations and aneuploidy in oral potentially malignant lesions: Distinctive features for tongue. BMC Cancer 11, 445 (2011
134. Mattila R, Alanen K, Syrjanen S. DNA content as a prognostic marker of oral lichen planus with a risk of cancer development. Anal. Quant. Cytol. Histol. 26(5), 278-284 (2004 (Pubitemid 39458647)
135. van Der Waal I, Schepman KP, van Der Meij EH, Smeele LE. Oral leukoplakia: A clinicopathological review. Oral Oncol. 33(5), 291-301 (1997 (Pubitemid 28129229)
136. Seoane J, Bascones A, Asenjo JA, Garcia-Pola M, Varela-Centelles PI. Flow cytometric analysis of nuclear DNA content in oral leukoplakia. Clin. Otolaryngol. Allied Sci. 23(2), 136-140 (1998 (Pubitemid 28344955)
137. Kahn MA, Dockter ME, Hermann-Petrin JM. Flow cytometer analysis of oral premalignant lesions: A pilot study and review. J. Oral Pathol. Med. 21(1), 1-6 (1992
138. Haroske G GF, Reith A, Bocking A. 1997 ESACP consensus report on diagnostic DNA image cytometry. Part I: basic considerations and recommendations for preparation, measurement and interpretation. European Society for Analytical Cellular Pathology. Anal. Cell. Pathol. 17(4), 189-200 (1997
139. Brennan M, Migliorati CA, Lockhart PB et al. Management of oral epithelial dysplasia: A review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 103(Suppl. S19), e11-e12 (2007
140. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A. Interventions for treating oral leukoplakia. Cochrane Database Syst. Rev. 4, CD001829 (2006
141. Braakhuis BJ, Leemans CR, Brakenhoff RH. A genetic progression model of oral cancer: Current evidence and clinical implications. J. Oral Pathol. Med. 33(6), 317-322 (2004 (Pubitemid 38931752)
142. Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ. Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am. J. Gastroenterol. 96(11), 3071-3083 (2001 (Pubitemid 33095344)
143. Merlo LM, Wang LS, Pepper JW, Rabinovitch PS, Maley CC. Polyploidy, aneuploidy and the evolution of cancer. Adv. Exp. Med. Biol. 676, 1-13 (2010
144. Giaretti W. Model of chromosomal instability in oral cancerogenesis and progression. In: Oral Cancer. Kalu U, Ogbureke E (Eds InTech, Rijeka, Croatia (2012